NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo

NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo

Item
http://www.wikidata.org/entity/Q28481887
Targeting the ubiquitin pathway for cancer treatmentCdc20: a potential novel therapeutic target for cancer treatmentCdc20 and securin overexpression predict short-term breast cancer survival.USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinomaA natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1Targeting Cdc20 as a novel cancer therapeutic strategy.The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy.Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cellsWMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages.E3 ubiquitin ligases in cancer and implications for therapies.WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells.
P2860

NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo

Item
http://www.wikidata.org/entity/Q28481887
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@ast
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@en
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@nl
type
label
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@ast
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@en
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@nl
prefLabel
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@ast
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@en
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
NAHA, a novel hydroxamic acid- ...... st cancer in vitro and in vivo
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0034283
P407
P433
P478
P577
P5875
P698
P932